A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis.

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Background:

• Accurate diagnosis of Zika virus (ZIKV) is crucial for patient care and disease control.
• Current serologic tests, like IgM-capture ELISA, suffer from cross-reactivity with other flaviviruses.
• Developing specific and rapid diagnostic tools for ZIKV is a significant public health need.

Purpose of the Study:

• To develop and evaluate a multiplex microsphere immunoassay (MIA) for the specific serologic diagnosis of ZIKV infection.
• To compare the diagnostic performance of MIA utilizing envelope and nonstructural proteins (NS1, NS5) against existing methods.
• To assess the potential of MIA for rapid, high-throughput ZIKV diagnostics.

Main Methods:

• A multiplex microsphere immunoassay (MIA) was designed using ZIKV envelope, NS1, and NS5 proteins.
• The assay was validated using 153 patient specimens with known ZIKV and/or dengue virus (DENV) infections.
• Performance metrics including sensitivity and specificity were compared against ZIKV IgM-capture ELISA.

Main Results:

• The ZIKV envelope-based MIA demonstrated sensitivity comparable or superior to IgM-capture ELISA.
• Antibody responses to ZIKV NS1 and NS5 proteins exhibited higher virus-type specificity than responses to the envelope protein.
• Incorporating NS1 and NS5 proteins into the MIA significantly enhanced diagnostic accuracy over envelope protein alone.

Conclusions:

• The developed multiplex MIA provides a rapid ( <4h) and specific serologic diagnostic tool for ZIKV infection.
• This assay overcomes the cross-reactivity limitations of current flavivirus diagnostic methods.
• The MIA holds promise for clinical diagnostics and monitoring immune responses in ZIKV vaccine trials.